BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19443633)

  • 1. Family history of renal disease severity predicts the mutated gene in ADPKD.
    Barua M; Cil O; Paterson AD; Wang K; He N; Dicks E; Parfrey P; Pei Y
    J Am Soc Nephrol; 2009 Aug; 20(8):1833-8. PubMed ID: 19443633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.
    Magistroni R; He N; Wang K; Andrew R; Johnson A; Gabow P; Dicks E; Parfrey P; Torra R; San-Millan JL; Coto E; Van Dijk M; Breuning M; Peters D; Bogdanova N; Ligabue G; Albertazzi A; Hateboer N; Demetriou K; Pierides A; Deltas C; St George-Hyslop P; Ravine D; Pei Y
    J Am Soc Nephrol; 2003 May; 14(5):1164-74. PubMed ID: 12707387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.
    Cornec-Le Gall E; Audrézet MP; Rousseau A; Hourmant M; Renaudineau E; Charasse C; Morin MP; Moal MC; Dantal J; Wehbe B; Perrichot R; Frouget T; Vigneau C; Potier J; Jousset P; Guillodo MP; Siohan P; Terki N; Sawadogo T; Legrand D; Menoyo-Calonge V; Benarbia S; Besnier D; Longuet H; Férec C; Le Meur Y
    J Am Soc Nephrol; 2016 Mar; 27(3):942-51. PubMed ID: 26150605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.
    Audrézet MP; Corbiere C; Lebbah S; Morinière V; Broux F; Louillet F; Fischbach M; Zaloszyc A; Cloarec S; Merieau E; Baudouin V; Deschênes G; Roussey G; Maestri S; Visconti C; Boyer O; Abel C; Lahoche A; Randrianaivo H; Bessenay L; Mekahli D; Ouertani I; Decramer S; Ryckenwaert A; Cornec-Le Gall E; Salomon R; Ferec C; Heidet L
    J Am Soc Nephrol; 2016 Mar; 27(3):722-9. PubMed ID: 26139440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
    Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients.
    Torra R; Badenas C; Pérez-Oller L; Luis J; Millán S; Nicolau C; Oppenheimer F; Milà M; Darnell A
    Am J Kidney Dis; 2000 Oct; 36(4):728-34. PubMed ID: 11007674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.
    Chebib FT; Jung Y; Heyer CM; Irazabal MV; Hogan MC; Harris PC; Torres VE; El-Zoghby ZM
    Nephrol Dial Transplant; 2016 Jun; 31(6):952-60. PubMed ID: 26932689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant polycystic kidney disease (ADPKD) in Tunisia: From molecular genetics to the development of prognostic tools.
    Abdelwahed M; Hilbert P; Ahmed A; Dey M; Bouomrani S; Kamoun H; Ammar-Keskes L; Belguith N
    Gene; 2022 Apr; 817():146174. PubMed ID: 35031424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type of PKD1 mutation influences renal outcome in ADPKD.
    Cornec-Le Gall E; Audrézet MP; Chen JM; Hourmant M; Morin MP; Perrichot R; Charasse C; Whebe B; Renaudineau E; Jousset P; Guillodo MP; Grall-Jezequel A; Saliou P; Férec C; Le Meur Y
    J Am Soc Nephrol; 2013 May; 24(6):1006-13. PubMed ID: 23431072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease.
    Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R
    Clin Lab; 2017 Jul; 63(7):1261-1267. PubMed ID: 28792715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
    Hoefele J; Mayer K; Scholz M; Klein HG
    Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review.
    Pietrzak-Nowacka M; Safranow K; Płońska-Gościniak E; Nowacki A; Późniak P; Gutowski P; Ciechanowski K
    Kidney Blood Press Res; 2024; 49(1):9-19. PubMed ID: 38096797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants.
    Raj S; Singh RG; Das P
    Mutat Res; 2020; 821():111718. PubMed ID: 32823016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing.
    Kim H; Park HC; Ryu H; Kim H; Lee HS; Heo J; Lee C; Kim NKD; Park WY; Hwang YH; Lee KB; Oh KH; Oh YK; Ahn C
    Sci Rep; 2019 Nov; 9(1):16952. PubMed ID: 31740684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families.
    Paul BM; Consugar MB; Ryan Lee M; Sundsbak JL; Heyer CM; Rossetti S; Kubly VJ; Hopp K; Torres VE; Coto E; Clementi M; Bogdanova N; de Almeida E; Bichet DG; Harris PC
    Kidney Int; 2014 Feb; 85(2):383-92. PubMed ID: 23760289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.